China AI Chip Unicorn Enflame Technology Clears STAR Market IPO Registration, Eyes RMB 6B Raise
Shanghai Enflame Technology received regulatory approval for its initial public offering on the Shanghai Stock Exchange's STAR Market on July 9, with its IPO registration status officially changing to "effective," according to the exchange's website. The listing, sponsored by CITIC Securities, took less than six months from acceptance to approval.
The green light marks a significant milestone not just for Enflame but for China's domestic GPU sector as a whole. With this approval, all four startups known as the "four dragons of domestic GPUs" — Moore Threads, Metax Technology, Biren Technology, and Enflame — are now on track to enter the public capital markets.
A Differentiated but Costly Technology Bet
Enflame focuses on cloud-based AI chips and intelligent computing clusters, positioning itself as a foundational infrastructure provider for general artificial intelligence. Unlike most domestic peers that rely on GPGPU architectures, Enflame has pursued a Domain-Specific Architecture (DSA) full-stack in-house development approach, alongside its proprietary "YuSuan" software platform.
The strategy carves out a differentiated niche and sidesteps direct competition within mainstream ecosystems, but it comes at a steep price. Research and development expenditures for 2023, 2024, and 2025 reached RMB 1.229 billion, RMB 1.312 billion, and RMB 1.135 billion, respectively — each year exceeding the company's total revenue for that period.
Revenue Growing, Losses Persisting
Revenue has grown steadily, rising from RMB 301 million (approximately US$41.5 million) in 2023 to RMB 722 million in 2024 and RMB 990 million in 2025. Yet profitability remains distant. Net losses attributable to shareholders of the parent company stood at RMB 1.665 billion, RMB 1.510 billion, and RMB 1.164 billion over the same three years, bringing cumulative losses to more than RMB 4.3 billion.
Operating cash flow has been negative throughout the reporting period, compounding concerns about the company's ability to sustain itself without external capital infusions.
Balance Sheet Strains Emerge
Beyond the headline losses, Enflame's balance sheet presents additional red flags for investors. Inventory at the end of 2025 stood at RMB 863 million — nearly equivalent to the company's full-year revenue — suggesting potential difficulties in converting product into sales. Meanwhile, the bad-debt provision ratio on accounts receivable climbed to 24.76%, raising questions about the quality of reported revenue and the company's collection capabilities.
Tencent: Both Backer and Biggest Customer
The company's most acute structural risk may be its concentration on a single related party. Tencent is simultaneously Enflame's largest shareholder, holding a 20.26% stake, and its largest customer. In 2025, sales to Tencent accounted for 83.79% of Enflame's total revenue — a dependency that leaves the company highly exposed to any shift in its anchor client's procurement strategy or capital allocation priorities.
IPO Proceeds Earmarked for Next-Generation Chips
Enflame plans to raise RMB 6 billion through the offering, with proceeds directed primarily toward the research, development, and commercialization of its fifth- and sixth-generation AI chips.
The listing resolves the company's immediate funding pressures, but investors will be watching closely to see whether Enflame can broaden its customer base, stabilize cash flows, and demonstrate that its business model can generate returns independently — challenges that will define its credibility as a publicly traded company in an increasingly competitive AI chip market.
Related Coverage:
Enflame Technology Goes Public, Reshaping China's AI Chip Landscape Amid Tencent Reliance